Iconic Therapeutics' Series B - III Round

Iconic Therapeutics raised a round of funding on April 16, 2014.

Iconic Therapeutics is a clinical stage biopharmaceutical company dedicated to translating an understanding of the role of Tissue Factor biology to new therapeutics for retinal disease and cancer. The…

Articles about Iconic Therapeutics' Series B - III Round: